Matches in SemOpenAlex for { <https://semopenalex.org/work/W2810088897> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- W2810088897 abstract "Introduction Cancer is one of the well-known illnesses leading to death. Clinical validations prove that protein kinases are an attractive class of therapeutic drug targets for cancer as demonstrated with the recent approval of six protein kinase inhibitors. The Warburg effect describes the particular reliance of cancer cells on glycolysis for energy. Increased glycolysis and acid resistance have been postulated to be an essential part of carcinogenesis, conferring a significant growth advantage as well as promoting typical tumour progression. Targeting accelerated glycolysis in cancer cells is a new promising modality for treatment of cancer. Inhibition of glycolysis can be done without significant side effects, and such treatment will be additive to most known cancer therapies. One way to inhibit the metabolism of cancer cells is to inhibit Hexokinase 2 (HK-2) enzyme. HK-2 has been studied in the field of cancer metabolism and hopeful results obtained. It has been also confirmed that HK-2 enzyme is expressed 10–15 times more in cancer cells than normal cells. Inhibition of HK-2 enzyme will prevent cancer cells from nutrition and and it is expected that speeding of cancer cells will presumably stop tumour growth. Material and methods Recent studies show that Methyl Jasmonate reveals promising results for treatment of cancer as a HK-2 inhibitor. Cis-jasmone, Jasmonic acid and Methyl jasmonate are cyclopentanones that are fatty acid derivatives. Jasmonates are plant stress hormones which exhibit abnormal anti-cancer activity.1 Jasmonates induced suppression of cell proliferation and death in a variety of cancer cell lines and cytotoxicity to cervical cancer cells with almost no effect on normal primary human keratinocytes.2 As a result of our research, although methyl jasmonate is long-known natural product, it has not well-studied as an anti cancer agent. Results and discussions In our research laboratory, we designed and synthesised handfull of novel methyl jasmonate analogues. We will highlight the biological activity results of those novel analogues as anti-cancer agents as well as their toxicologic profiles will be highligted. Conclusion As a result of this study, we have identified several novel methyl jasmonate analogues that are much more potent in biological assays. Based on the synthetic feasibility and freedom of operation of methyl jasmonate molecule, additional druggable analogues are also being investigated in our research. This project (215 S890) is funded by TUBITAK. We kindly appreciate for their support." @default.
- W2810088897 created "2018-07-10" @default.
- W2810088897 creator A5012340059 @default.
- W2810088897 creator A5013905468 @default.
- W2810088897 creator A5013979957 @default.
- W2810088897 creator A5028128267 @default.
- W2810088897 date "2018-06-01" @default.
- W2810088897 modified "2023-09-24" @default.
- W2810088897 title "PO-412 Novel drug discovery approaches for cancer with the inspiration of a natural product – methyl jasmonate" @default.
- W2810088897 doi "https://doi.org/10.1136/esmoopen-2018-eacr25.438" @default.
- W2810088897 hasPublicationYear "2018" @default.
- W2810088897 type Work @default.
- W2810088897 sameAs 2810088897 @default.
- W2810088897 citedByCount "0" @default.
- W2810088897 crossrefType "journal-article" @default.
- W2810088897 hasAuthorship W2810088897A5012340059 @default.
- W2810088897 hasAuthorship W2810088897A5013905468 @default.
- W2810088897 hasAuthorship W2810088897A5013979957 @default.
- W2810088897 hasAuthorship W2810088897A5028128267 @default.
- W2810088897 hasBestOaLocation W28100888971 @default.
- W2810088897 hasConcept C104317684 @default.
- W2810088897 hasConcept C109156525 @default.
- W2810088897 hasConcept C121608353 @default.
- W2810088897 hasConcept C181199279 @default.
- W2810088897 hasConcept C184235292 @default.
- W2810088897 hasConcept C185592680 @default.
- W2810088897 hasConcept C20251656 @default.
- W2810088897 hasConcept C2777942875 @default.
- W2810088897 hasConcept C2778221352 @default.
- W2810088897 hasConcept C2779080361 @default.
- W2810088897 hasConcept C502942594 @default.
- W2810088897 hasConcept C54355233 @default.
- W2810088897 hasConcept C55493867 @default.
- W2810088897 hasConcept C555283112 @default.
- W2810088897 hasConcept C86803240 @default.
- W2810088897 hasConcept C96232424 @default.
- W2810088897 hasConceptScore W2810088897C104317684 @default.
- W2810088897 hasConceptScore W2810088897C109156525 @default.
- W2810088897 hasConceptScore W2810088897C121608353 @default.
- W2810088897 hasConceptScore W2810088897C181199279 @default.
- W2810088897 hasConceptScore W2810088897C184235292 @default.
- W2810088897 hasConceptScore W2810088897C185592680 @default.
- W2810088897 hasConceptScore W2810088897C20251656 @default.
- W2810088897 hasConceptScore W2810088897C2777942875 @default.
- W2810088897 hasConceptScore W2810088897C2778221352 @default.
- W2810088897 hasConceptScore W2810088897C2779080361 @default.
- W2810088897 hasConceptScore W2810088897C502942594 @default.
- W2810088897 hasConceptScore W2810088897C54355233 @default.
- W2810088897 hasConceptScore W2810088897C55493867 @default.
- W2810088897 hasConceptScore W2810088897C555283112 @default.
- W2810088897 hasConceptScore W2810088897C86803240 @default.
- W2810088897 hasConceptScore W2810088897C96232424 @default.
- W2810088897 hasLocation W28100888971 @default.
- W2810088897 hasOpenAccess W2810088897 @default.
- W2810088897 hasPrimaryLocation W28100888971 @default.
- W2810088897 hasRelatedWork W125173673 @default.
- W2810088897 hasRelatedWork W14731582 @default.
- W2810088897 hasRelatedWork W1558118119 @default.
- W2810088897 hasRelatedWork W1916235144 @default.
- W2810088897 hasRelatedWork W2005324267 @default.
- W2810088897 hasRelatedWork W2042358042 @default.
- W2810088897 hasRelatedWork W22731796 @default.
- W2810088897 hasRelatedWork W2315301857 @default.
- W2810088897 hasRelatedWork W2603179175 @default.
- W2810088897 hasRelatedWork W27973947 @default.
- W2810088897 hasRelatedWork W2806111062 @default.
- W2810088897 hasRelatedWork W2884245587 @default.
- W2810088897 hasRelatedWork W3006246094 @default.
- W2810088897 hasRelatedWork W3014029208 @default.
- W2810088897 hasRelatedWork W3093584619 @default.
- W2810088897 hasRelatedWork W3139191950 @default.
- W2810088897 hasRelatedWork W3162474259 @default.
- W2810088897 hasRelatedWork W3178723237 @default.
- W2810088897 hasRelatedWork W1572468130 @default.
- W2810088897 hasRelatedWork W2182595530 @default.
- W2810088897 isParatext "false" @default.
- W2810088897 isRetracted "false" @default.
- W2810088897 magId "2810088897" @default.
- W2810088897 workType "article" @default.